DJ Vion Pharm 1Q Losses 18c A Share Vs 32c
Vion Pharmaceuticals Inc. New Haven, Conn.
1st Quar March 31:
1999 1998
Revenue $371,414 $274,842
Net income (2,432,229) (2,506,220)
Avg shrs (basic) 14,034,943 9,891,509
Shr earns (basic)
Net income (.18) (.32)
Shr earns (diluted)
Net income 0.00 0.00
Figures in parentheses are losses.
Vion Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops and commercializes products to treat cancer and viral diseases.
DJ Novavax/Pres/CEO-2: Spears Was Vion Pharma Pres/CEO
Dow Jones Newswires
COLUMBIA, Md. -- Novavax Inc. (NOX) named John A. Spears president and chief executive, replacing Mitchell J. Kelly, who served on an interim basis.
In a press release Monday, the biopharmaceutical company said Spears was also named a director.
Spears was previously president and chief executive of Vion Pharmaceuticals Inc. (VION), Novavax said
Sorry about the formatting of the table. Can not figure out how to get it right! Ugh.
Jim
|
